{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:15:32Z","timestamp":1778944532861,"version":"3.51.4"},"reference-count":47,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.1253\/circj.cj-24-0436","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:14:16Z","timestamp":1728598456000},"page":"354-363","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy in Japanese Ischemic Heart Disease Patients"],"prefix":"10.1253","volume":"89","author":[{"given":"Kenji","family":"Hanada","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kinjo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Shikanai","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Senoo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritomo","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Shibutani","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Emergency and Disaster Medicine, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Kumamoto Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yokoshiki H, Shimizu A, Mitsuhashi T, Ishibashi K, Kabutoya T, Yoshiga Y, et al. Trends in the use of implantable cardioverter-defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database. <i>J Arrhythm<\/i> 2020; 36: 737\u2013745.","DOI":"10.1002\/joa3.12377"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, at al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? <i>Circ J<\/i> 2005; 69: 19\u201322.","DOI":"10.1253\/circj.69.19"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kuga K, Yamasaki H, Hattori A, Xu DZ, Watanabe S, Arimoto T, et al. Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era: Subanalysis of the Japanese Coronary Artery Disease (JCAD) study. <i>Circ J<\/i> 2014; 78: 2483\u20132491.","DOI":"10.1253\/circj.CJ-14-0301"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II Registry. <i>Heart<\/i> 2009; 95: 216\u2013220.","DOI":"10.1136\/hrt.2008.145243"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hanada K, Sasaki S, Seno M, Kimura Y, Ichikawa H, Nishizaki F, et al. Reduced left ventricular ejection fraction is a risk for sudden cardiac death in the early period after hospital discharge in patients with acute myocardial infarction. <i>Circ J<\/i> 2022; 86: 1490\u20131498.","DOI":"10.1253\/circj.CJ-21-0999"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ueda N, Noda T, Kusano K, Yasuda S, Kurita T, Shimizu W. Use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in Asia. <i>JACC Asia<\/i> 2023; 3: 335\u2013345.","DOI":"10.1016\/j.jacasi.2023.02.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. <i>Circulation<\/i> 2018; 138: e210\u2013e271.","DOI":"10.1161\/CIR.0000000000000615"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, et al. JCS\/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2022; 86: 337\u2013363.","DOI":"10.1253\/circj.CJ-21-0162"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy. <i>Circulation<\/i> 2010; 122: 985\u2013992.","DOI":"10.1161\/CIRCULATIONAHA.110.955039"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, et al. Characterization of super-response to cardiac resynchronization therapy. <i>Heart Rhythm<\/i> 2010; 7: 885\u2013889.","DOI":"10.1016\/j.hrthm.2010.04.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia\/fibrillation: Findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). <i>J Am Coll Cardiol<\/i> 2005; 46: 1712\u20131720.","DOI":"10.1016\/j.jacc.2005.05.088"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA 3rd, Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. <i>J Cardiovasc Electrophysiol<\/i> 2008; 19: 784\u2013789.","DOI":"10.1111\/j.1540-8167.2008.01111.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. van Welsenes GH, van Rees JB, Borleffs CJ, Cannegieter SC, Bax JJ, van Erven L, et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. <i>Europace<\/i> 2011; 13: 389\u2013394.","DOI":"10.1093\/europace\/euq494"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sabbag A, Suleiman M, Laish-Farkash A, Samania N, Kazatsker M, Goldenberg I, et al. Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry. <i>Heart Rhythm<\/i> 2015; 12: 2426\u20132433.","DOI":"10.1016\/j.hrthm.2015.08.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Borleffs CJ, van Erven L, Schotman M, Boersma E, Ki\u00e8s P, van der Burg AE, et al. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: Long-term follow-up of the Leiden Out-of-Hospital Cardiac Arrest study (LOHCAT). <i>Eur Heart J<\/i> 2009; 30: 1621\u20131626.","DOI":"10.1093\/eurheartj\/ehp234"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. An Y, Ando K, Soga Y, Nomura A, Nagashima M, Hayashi K, et al. Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria. <i>J Arrhythm<\/i> 2017; 33: 17\u201322.","DOI":"10.1016\/j.joa.2016.01.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kabutoya T, Mitsuhashi T, Shimizu A, Nitta T, Mitamura H, Kurita T, et al. Prognosis of Japanese patients with coronary artery disease who underwent implantable cardioverter defibrillator implantation: The JID-CAD study. <i>Circ Rep<\/i> 2021; 3: 69\u201376.","DOI":"10.1253\/circrep.CR-20-0122"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kondo Y, Noda T, Sato Y, Ueda M, Nitta T, Aizawa Y, et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score-matched analysis from the Nippon Storm Study. <i>Heart Rhythm O2<\/i> 2021; 2: 5\u201311.","DOI":"10.1016\/j.hroo.2020.12.020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kotake Y, Yasuoka R, Tanaka M, Noda T, Nitta T, Aizawa Y, et al. Comparison of second appropriate defibrillator therapy occurrence in patients implanted for primary prevention and secondary prevention: Sub-analysis of the Nippon Storm Study. <i>Int J Cardiol Heart Vasc<\/i> 2021; 32: 100704.","DOI":"10.1016\/j.ijcha.2020.100704"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nagahara D, Fujito T, Mochizuki A, Shimoshige S, Hashimoto A, Miura T. Predictors of appropriate ICD therapy in Japanese patients with structural heart diseases: A major role of prior sustained ventricular tachycardia in secondary prevention. <i>J Arrhythm<\/i> 2018; 34: 527\u2013535.","DOI":"10.1002\/joa3.12086"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim MH, Zhang Y, Sakaguchi S, Goldberger JJ. Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions. <i>Heart Rhythm<\/i> 2015; 12: 1728\u20131736.","DOI":"10.1016\/j.hrthm.2015.04.037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Darma A, Nedios S, Kosiuk J, Richter S, Doering M, Arya A, et al. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. <i>Europace<\/i> 2016; 18: 405\u2013412.","DOI":"10.1093\/europace\/euv138"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hanada K, Kinjo T, Yokoyama H, Tsushima M, Senoo M, Ichikawa H, et al. Incidence, predictors, and outcome associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. <i>Circ J<\/i> 2024; 88: 1254\u20131264.","DOI":"10.1253\/circj.CJ-23-0023"},{"key":"25","unstructured":"25. World Health Organization. Global health estimates: Leading causes of death. Accessed October 2, 2022. https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/ghe-leading-causes-of-death."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nagata M, Ninomiya T, Doi Y, Hata J, Ikeda F, Mukai N, et al. Temporal trends in sudden unexpected death in a general population: The Hisayama study. <i>Am Heart J<\/i> 2013; 165: 932\u2013938.e1.","DOI":"10.1016\/j.ahj.2013.02.028"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. <i>Circ J<\/i> 2015; 79: 381\u2013390.","DOI":"10.1253\/circj.CJ-14-0925"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation. <i>J Am Coll Cardiol<\/i> 2002; 39: 1323\u20131328.","DOI":"10.1016\/S0735-1097(02)01784-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pierce AE, Roppolo LP, Owens PC, Pepe PE, Idris AH. The need to resume chest compressions immediately after defibrillation attempts: An analysis of post-shock rhythms and duration of pulselessness following out-of-hospital cardiac arrest. <i>Resuscitation<\/i> 2015; 89: 162\u2013168.","DOI":"10.1016\/j.resuscitation.2014.12.023"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Duray GZ, Schmitt J, Richter S, Israel CW, Hohnloser SH. Arrhythmic death in implantable cardioverter defibrillator patients: A long-term study over a 10 year implantation period. <i>Europace<\/i> 2009; 11: 1462\u20131468.","DOI":"10.1093\/europace\/eup246"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD. Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses. <i>J Am Coll Cardiol<\/i> 1999; 33: 24\u201332.","DOI":"10.1016\/S0735-1097(98)00519-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. <i>Heart Rhythm<\/i> 2016; 13: e50\u2013e86.","DOI":"10.1016\/j.hrthm.2015.11.018"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, et al. Complications associated with defibrillation threshold testing: The Canadian experience. <i>Heart Rhythm<\/i> 2008; 5: 387\u2013390.","DOI":"10.1016\/j.hrthm.2007.11.018"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mollerus M, Naslund L. Myocardial stunning following defibrillation threshold testing. <i>J Interv Card Electrophysiol<\/i> 2007; 19: 213\u2013216.","DOI":"10.1007\/s10840-007-9150-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H, et al. Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. <i>Am Heart J<\/i> 1994; 127: 1064\u20131067.","DOI":"10.1016\/0002-8703(94)90088-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: Implications for antiarrhythmic therapy and driving restrictions. CARE Group. <i>J Am Coll Cardiol<\/i> 2001; 37: 1910\u20131915.","DOI":"10.1016\/S0735-1097(01)01226-8"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Elsokkari I, Parkash R, Tang A, Wells G, Doucette S, Yetisir E, et al. Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators. <i>JACC Clin Electrophysiol<\/i> 2020; 6: 327\u2013337.","DOI":"10.1016\/j.jacep.2019.11.012"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Suzuki T, Shiga T, Kuwahara K, Kobayashi S, Suzuki S, Nishimura K, et al. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: A 2-year longitudinal study. <i>Pacing Clin Electrophysiol<\/i> 2010; 33: 1455\u20131461.","DOI":"10.1111\/j.1540-8159.2010.02887.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Samuel M, Healey JS, Nault I, Sterns LD, Essebag V, Gray C, et al. Ventricular tachycardia and ICD therapy burden with catheter ablation versus escalated antiarrhythmic drug therapy. <i>JACC Clin Electrophysiol<\/i> 2023; 9: 808\u2013821.","DOI":"10.1016\/j.jacep.2023.01.030"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. <i>N Engl J Med<\/i> 1997; 337: 1576\u20131583.","DOI":"10.1056\/NEJM199711273372202"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Boul\u00e9 S, S\u00e9michon M, Gu\u00e9don-Moreau L, Drumez \u00c9, Kouakam C, Marqui\u00e9 C, et al. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death. <i>Arch Cardiovasc Dis<\/i> 2016; 109: 517\u2013526.","DOI":"10.1016\/j.acvd.2016.02.008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Komatsu Y, Hocini M, Nogami A, Maury P, Peichl P, Iwasaki YK, et al. Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction. <i>Circulation<\/i> 2019; 139: 2315\u20132325.","DOI":"10.1161\/CIRCULATIONAHA.118.037997"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Raitt MH, Dolack GL, Kudenchuk PJ, Poole JE, Bardy GH. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: Implications for use of implantable defibrillator. <i>Circulation<\/i> 1995; 91: 1996\u20132001.","DOI":"10.1161\/01.CIR.91.7.1996"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, et al. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: Results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. <i>Circulation<\/i> 2014; 130: 2278\u20132286.","DOI":"10.1161\/CIRCULATIONAHA.114.011283"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). <i>Eur Heart J<\/i> 2015; 36: 2793\u20132867.","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Sabbag A, Glikson M, Suleiman M, Boulos M, Goldenberg I, Beinart R, et al. Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator. <i>Heart Rhythm<\/i> 2019; 16: 813\u2013819.","DOI":"10.1016\/j.hrthm.2019.03.030"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Higuma T, Akashi YJ, Fukumoto Y, Obara H, Kakuma T, Asaumi Y, et al. Residual coronary risk factors associated with long-term clinical outcomes in patients with coronary artery disease treated with high- vs. low-dose statin therapy: REAL-CAD substudy. <i>Circ J<\/i> 2024; 88: 995\u20131003.","DOI":"10.1253\/circj.CJ-23-0134"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/3\/89_CJ-24-0436\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:19:10Z","timestamp":1740799150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/3\/89_CJ-24-0436\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0436","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"CJ-24-0436"}}